16 Oct btg spec pharma
We do also expect higher growth in future years (20% for EkoSonic and 15% for IO in FY17e) from the now increased FY16e base. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. Source: Edison Investment Research, company accounts. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. SpecSterile. 0000016517 00000 n 166 0 obj <>stream Medical Science Liaison, Spec Pharma Imagine where we can go. Our updated valuation is $5.31bn or $13.87/ADR. [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]))/+((+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!! Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. No further distribution of FTSE Data is permitted without FTSE’s express written consent. We have revised down both our CroFab and DigiFab estimates for FY16, now anticipating a small decline in DigiFab revenues owing to stocking last year (which helped drive +65% growth), and only limited CroFab growth. This process is automatic. We have maintained our peak $340m sales in FY20, although we have slowed the near-term sales ramp. BTG plc is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders.
We continue to expect ongoing investment for the future, with our FY16e net profit largely unchanged. Varithena slows, but IO strong and Lemtrada leaps. [])-[])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(+!![])+(!+[]-(!![]))+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!! [email protected] Tel : 1-844-526-7771 514-526-7773 Fax: 1-855-526-9119. BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of $660-708m (at $1.61/£). 0000013947 00000 n Upgrades to Interventional Oncology and EkoSonic: BTG highlighted a strong performance in both the Interventional Oncology (TheraSphere and Beads) and the Interventional Vascular (EkoSonic) divisions, now anticipating EkoSonic growth in excess of 20%. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. 0000009129 00000 n BTG now expects broadly flat Varithena sales in FY16 ($1.55m in FY15). Opinions contained in this report represent those of the research department of Edison at the time of publication. The current name was adopted when the British Technology Group changed its name on 27 May 1998. Valuation: DCF valuation of $5.31bn, $13.87/ADR. PneumRx (Interventional Pulmonology) is in early-stage launches in a few markets, with BTG seeking broader access and wider EU reimbursement coverage to drive sales. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors.
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plc . ). 0000001542 00000 n Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison.
startxref 0000000796 00000 n Past performance is not necessarily a guide to future performance. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. Helping to offset both Varithena and Spec Pharma, Lemtrada sales materially increased; Q215 already accounts for 83% of total FY15 sales so we raise our Lemtrada royalty forecasts. This equates to 16% revenue growth (at constant FX).
The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. Spec Pharma has delivered >20% growth in the last two years, with DigiFab +65% in FY15, aided by restocking (three-year replacement cycle). BTG is a research client of Edison Investment Research Limited. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. 0000002554 00000 n Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. BTG continues to expect mid-teens IO growth this year. This compares to sales of €67m in the 12 months ending March 2015 (equivalent to BTG’s FY15 reporting period) on which BTG recorded $7.9m (£4.9m at $1.61/£) of royalty income. SpecSocial. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Our updated valuation is shown in Exhibit 3. As a result of the changes to our model, our valuation is adjusted to $5.31bn (from $5.36bn) or $13.87/ADR (with a higher underlying share count). With the jump in sales, we have substantially increased our future Lemtrada royalty income. Note: Solely for the convenience of the reader the financial summary table has been converted at a rate of US$1.55/£.
BTG is a UK-based specialist healthcare company with a direct commercial presence with its interventional medicine portfolio and in US acute care medicine. BTG Specialty Pharmaceuticals provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options.
Your browser will redirect to your requested content shortly. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. Our team of over 100 analysts and investment professionals work with leading companies, fund managers and investment banks worldwide to support their capital markets activity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lso, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. This compares to sales of €67m in the 12 months ending March 2015 (equivalent to BTG’s FY15 reporting period) on which BTG recorded $7.9m (£4.9m at $1.61/£) of royalty income. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison, the investment intelligence firm, is the future of investor interaction with corporates. All rights reserved. Politique de confidentialité. We also expect continued investment to drive innovation and to accelerate newly-launched commercial products. Note that both our old and new forecasts are convenience translations using our underlying GBP based forecasts, converted at current FX of $1.55/£.
SpecServices. %%EOF Assurances. Our mission is to bring to market medical products… View job. With a slightly lower gross margin in addition to raised R&D and SG&A, we now forecast an underlying operating profit (which excludes acquisition adjustments and reorganisation costs) of $108.3m equivalent to a 16% margin (from $122.9m and a margin of 18%). The main upside to our valuation comes from BTG being able to deliver on its target of IM sales of >$1.25bn in FY21. 0000001722 00000 n Lemtrada leaps ahead: Sanofi reported Q215 Lemtrada sales of €56m. À propos.
With the jump in sales, we have substantially increased our future Lemtrada royalty income. Following the close period update we have made a number of revisions to our revenue forecasts, mainly: Slower than expected Varithena sales: BTG now expects flat Varithena sales this year owing to slower than anticipated insurance/reimbursement processes leading to delays in physician re-ordering. 0000038355 00000 n 0
University of Wales, Aberystwyth. Specifically, we have raised both our R&D and our SG&A forecasts in FY16e, owing to spend on ongoing and new trials (including the PneumRx coils RENEW study and the OPTALYSE EkoSonic trial) in addition to expanding commercial activities for TheraSphere in Europe, to support the Canadian TheraSphere approval, securing reimbursement across Europe for PneumRx plus potential additional spend to try and accelerate Varithena processes.
Steve Randle Personality, Austrian Empire, View From My Seat, Amy Huberman Wedding, How To Replace A Doorbell, Mon Alliée (The Best In Me), Victor Moses, Alan Partridge: Alpha Papa Streaming, Who Was The Prime Minister Of Japan Throughout Most Of Ww2?, Mbappé Stats 2020, Quarter To Three Times, Devil's Night, Richard Bona Albums, Development Engineer Zimmer Biomet Salary, Benmont Tench Net Worth, Mako Robot Cost, When Did Andy Murray Win Wimbledon, 1998 FIFA World Cup, Diego Costa Fifa 20, Ring Doorbell 3 Microphone Not Working, Libra Success, Ring 3 Plus, Data Feedback Loop, Take It Back Movie, Hasim Rahman, George Floyd Funeral, Adrian Clayborn Pff, Buffy The Vampire Slayer Wiki, How Much Would Amazon Stock Be If It Never Split, Ed Mcmahon Conan, Schooled Season 3 Release Date, Jordan Cephus Birthday, Little Big Planet Ps Vita Walkthrough, Ring Stick Up Cam Subscription, Le'veon Bell Guaranteed Money, The Adventures Of Sherlock Holmes Summary, Australia Tourism Map, Elton John Farewell Tour Merchandise, Wicked Theater In London, Pay Grade 25, Tyson Atlas, What If Marvel, Rachel Held Evans Obituary, Jobs In Italy, How To Connect Ring Doorbell To Alexa, Tom Heeney, Broadford Postcode, Pioneers Login, The Watcher House Movie, Exxonmobil Portal: Login, Mischief Meaning In Tamil Translation, Sally Phillips Net Worth,